Intralesional versus intramuscular bivalent human papillomavirus vaccine in the treatment of recalcitrant common warts

Despite the availability of different therapeutic modalities, treatment of recalcitrant common warts is still challenging. Cervarix, a recombinant bivalent human papillomavirus (HPV) vaccine, has shown promising efficacy in the treatment of warts.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: Source Type: research

Related Links:

ConclusionsWe found significant disparities in HPV vaccine series completion rates among male patients based on race and insurance, unchanged based on era of initiation or visit frequency.
Source: Academic Pediatrics - Category: Pediatrics Source Type: research
An analysis covering 66 million young people has found plummeting rates of precancerous lesions and genital warts after vaccination against the human papillomavirus.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Human Papillomavirus (HPV) Women and Girls Vaccination and Immunization Cervical Cancer Sexually Transmitted Diseases Warts Gardasil (Vaccine) Third World and Developing Countries Centers for Disease Control and Prevention Lancet, The (J Source Type: news
By Jacqueline Howard, CNN (CNN) — The US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, known as ACIP, voted unanimously on Wednesday to recommend HPV vaccines for both boys and girls and men and women through age 26. Previously the CDC recommended that teen girls and young women who had not been adequately vaccinated receive the human papillomavirus vaccine through age 26, but the recommendation for teen boys and young men only went through age 21. The CDC’s recommendation that children start receiving two doses of the HPV vaccine around 11 or 12...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News CNN HPV vaccine Source Type: news
Human papillomavirus (HPV) infections are associated with common dermatological and non-dermatological diseases. While HPV vaccines are well-established as preventive measures for genital warts and cervical neoplasia, their use as therapeutic agents deserves greater attention.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: Source Type: research
Authors: Steben M, Tan Thompson M, Rodier C, Mallette N, Racovitan V, DeAngelis F, Stutz M, Rampakakis E Abstract Publicly funded administration of the quadrivalent HPV (qHPV) vaccine in school-aged girls was implemented for all Canadian provinces and territories between 2007 and 2009. However, the impact of female qHPV vaccination in Canada has yet to be evaluated. This systematic literature review of studies published between September 1, 2006 and September 1, 2016 looked at real-world evidence related to the effects of qHPV vaccination on prevalence of HPV infection and disease in Canada over the past decade. Pu...
Source: Journal of Obstetrics and Gynaecology Canada : JOGC - Category: OBGYN Tags: J Obstet Gynaecol Can Source Type: research
Adults up to age 45 can now be vaccinated against human papillomavirus (HPV), reducing their chances of getting cervical, oral and other cancers. The Food and Drug Administration (FDA) announced Friday that Gardasil 9, a vaccine that works against nine different types of HPV, is now approved for both men and women between the ages of 27 and 45. Previously, it was approved only for those between the ages of nine and 26, and recommended for all children at age 11 or 12. “Today’s approval represents an important opportunity to help prevent HPV-related diseases and cancers in a broader age range,” Dr. Peter M...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized healthytime onetime public health Source Type: news
This study explores the general knowledge of Human Papillomavirus vaccine (HPV) and cervical cancer screening (CCS) among Somali men in the U.S., who are major decision-makers in Somali households. HPV infects both men and women, and causes genital warts and cervical cancer (CC). High mortality from CC persists among minorities due to low uptake of preventive tools. Eleven questions assessed general knowledge of HPV and CCS among 30 Somali male respondents. The knowledge of HPV and CCS by education level, age, and years lived in the U.S., was assessed using the health belief model. Most respondents had no knowledge of HPV ...
Source: Journal of Immigrant and Minority Health - Category: International Medicine & Public Health Source Type: research
Objective The aim of the study was to investigate the effects of 3 or less quadrivalent human papillomavirus (HPV) vaccine doses on anogenital warts in both males and females in the United States. Materials and Methods We conducted a retrospective database study that included males and females aged 9 to 26 years who received varying numbers of vaccine doses between 2006 and 2015. The primary outcome was the incidence of anogenital warts starting 3 months after the last dose of the HPV vaccine. Proportional hazard regression models were used to examine the association between the number of HPV vaccine doses and the inc...
Source: Journal of Lower Genital Tract Disease - Category: OBGYN Tags: Original Research Articles: Cervix and HPV Source Type: research
This study looks at a collection of studies looking at the benefit of HPV vaccines in reducing pre cervical cancer lesions.  HPV also causes many other serious cancers (especially head and neck).  In time, as more people have been vaccinated, we will see a reduction in all HPV cancers.  The HP V vaccine is one of a number of vaccines using virus like particles (VLPS) which have been shown to be very safe over the last 35 years. “The Cochrane library of reviews has a very rigorous assessment process of all their reviews. “The review only looked at cervical precancer (in women and girls),...
Source: Cochrane News and Events - Category: Information Technology Authors: Source Type: news
Date: May 7, 2018 Issue #:  1546Summary:  The US Advisory Committee on Immunization Practices (ACIP) recommends routine use of the following vaccines in adults residing in the US: influenza, tetanus/diphtheria alone (Td) and in combination with acellular pertussis (Tdap), measles/mumps/rubella (MMR), varicella (VAR), herpes zoster (RZV; ZVL), human papillomavirus (HPV), and pneumococcal conjugate (PCV13) and polysaccharide (PPSV23) vaccines. For adults with certain medical conditions or occupational, behavioral, or other risk factors, hepatitis A (HepA), hepatitis B (HepB), meningococcal (MenAC...
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: Tags: ActHIB Avaxim Bexsero Boostrix Cervarix diphtheria Engerix-B Gardasil Gardasil9 Genital warts Haemophilus infuenzae Havrix hepatitis a hepatitis b Heplisav-B Hiberix HPV vaccine Influenza vaccine measles Menactra Me Source Type: research
More News: Academies | Cervical Cancer Vaccine | Dermatology | Gardasil | Genital Warts | Human Papillomavirus (HPV) | Skin | Vaccines | Warts